Microbiosci Provides Microbial Metabolomics Services with Advanced Instruments and State-of-the-art Multivariate Data Analyses

Microbiosci announced the release of microbial metabolomics services in order to assist scientists in utilizing metabolomics for achieving research goals.

New York, USA – April 30, 2021 – Microbiosci, the branch of Creative Biogene, which is the world’s leading biotechnology products and services provider, focuses on providing a wide range of high quality products in microbial genome editing, identification, sequencing, proteomics and metabolomics aiming to deliver medicine microbiology solutions to clinical, pharmaceutical and veterinary by infection detection, prevention and novel pharmaceutical protein production. Recently, Microbiosci announced the release of microbial metabolomics services in order to assist scientists in utilizing metabolomics for achieving research goals.

As a service provider of microbial metabolomics, Microbiosci uses advanced instruments and the latest multivariate data analysis. Metabolomics aims to identify biomarkers, clarify the mode of action, and characterize products and processes. Microbiosci’s metabolomics solutions based on LC-MS, GC-MS and NMR fully meet the requirements of integrated metabolic profiling, sample throughput, compound identification, verification and quantification. In order to obtain metabolome data representing the physiological state of microorganisms, validated protocols and analyses are essential. The solutions provided by Mirobiosci are tailor-made for corresponding research purposes, combining innovative hardware with the versatility of data processing.

Microbiosci provides non-target metabolomics services. With its advanced facilities with experienced scientists, it will provide unparalleled expertise to assist researchers in non-target metabolomics analysis. In addition, Microbiosci can also provide a variety of options to save the time and cost of the discovery process, and perform non-target metabolomics research for partners in the pharmaceutical and academic research fields. This includes research across various disease indications from in vitro models to clinical studies.

Microbiosci has a wide range of targeted metabolic pathways and targeted metabolite analysis services to meet the needs of specific projects. As a leading company providing high-quality targeted metabolomics services, talented scientists have extensive experience in the quantitative measurement of target metabolite compounds using high pressure liquid chromatography and mass spectrometry. To provide target metabolic pathways and target metabolite analysis services to identify and quantify target small molecules in organisms.

“Microbiosci is committed to helping you use metabolomics to achieve your research goals. In order to promote the research, we design a complete process from the initial consultation to the generation of metabolomics data.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “The whole process is dedicated to giving you wise decision-making power so that you can move forward with confidence. We will be very happy to discuss your project and the potential of applying metabolomics with you.”

About Microbiosci

Microbiosci, as the division of Creative Biogene, is always dedicated to satisfying the needs of clients covering more than 50 countries and districts. As a leading custom service provider in delivering medicine microbiology solutions, Microbiosci has become a well-recognized industry leader with years of experience and professional scientists.

Media Contact
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-386-8241
Country: United States
Website: https://microbiosci.creative-biogene.com